The ranking covers 100 companies counted by patent records, with a steep concentration at the top: the leading assignee alone holds 2,576 records, compared with 390 at fifth place and 246 at tenth. The five leading assignees together account for 51.0% of all 10,621 records in scope, and that share rises to 64.7% across the ten leading assignees. This means most of the claim space in this field is held by a small number of filers, with a long tail of smaller entrants making up the remainder.

Filing volume peaked in 2022 at 1,340 records and has since eased, falling -28% from 1,247 in 2021 to 902 in 2024, the most recent year that can be treated as complete. Data for 2025 and 2026 will still rise as publications catch up, since publication typically lags filing by around 18 months. Read the recent dip as a data-lag effect rather than confirmed evidence that the technology is losing filer interest.

The corpus splits across two distinct classification clusters: a communications-network cluster led by H04W (67.7% of records) and H04L (35.9%), and a smaller biological-processing cluster covering C12N microorganisms and genetic engineering (10.5%), A61K medicinal preparations (7.8%) and C07K peptides and proteins (6.6%). Because a single record can carry multiple IPC classes, these shares add up to more than 100% and should not be summed as if they were mutually exclusive categories. The overlap suggests the search terms capture both network-architecture filings and cell-processing hardware filings that happen to share vocabulary like 'processing time' and 'selection.'

WO2026043806A2, filed by Life Technologies Corporation and published 2026-02-26, describes a functionally closed integrated system that combines counterflow centrifugation with bead processing and optional electroporation in a single housing for cell isolation, de-beading and electroporation assays. It is useful as a representative record because it shows how current filings bundle multiple processing steps — separation, bead removal and electroporation — into one claimed system rather than protecting each step separately. Anyone designing a modular or single-step alternative should review its specific housing and valve-assembly claims closely.

The lighter-filed branches sit around label-free selection assays, bead-removal verification methods, starting-material variability controls, and processing-time reduction claims — areas named directly in the search terms but not carrying the same filing density as the core separation methods. These branches are worth a dedicated freedom-to-operate check rather than an assumption of open space, since a light count in this dataset reflects search-term coverage, not a guarantee of no prior art. Combining a specific technical mechanism with one of these outcome claims is a reasonable place to start a novelty search.